Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis C

BACKGROUND: In 2019, the Utilization Review Accreditation Commission (URAC) required a new reporting measure for specialty pharmacies related to completion of therapy for hepatitis C virus (HCV). OBJECTIVE: To calculate HCV completion of therapy according to URAC criteria and compare it with a calcu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolduc, Clay, McCall, Kenneth, Stickney, Kirsten, Gelinas, Alycia, Levesque, Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391126/
https://www.ncbi.nlm.nih.gov/pubmed/33506724
http://dx.doi.org/10.18553/jmcp.2021.27.2.263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391126/
https://www.ncbi.nlm.nih.gov/pubmed/33506724
http://dx.doi.org/10.18553/jmcp.2021.27.2.263

Ejemplares similares